Pegcetacoplan in Combination With Modified FOLFIRINOX for the Treatment of Metastatic Pancreatic Ductal Adenocarcinoma
Abroad (travel likely)RecruitingPHASE1, PHASE2
Conditions
Metastatic Pancreatic Ductal Adenocarcinoma · Stage IV Pancreatic Cancer AJCC v8
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
Roswell Park Cancer Institute, Buffalo, New York, United States
Contact: Principal Investigator (Christos Fountzilas)
Study leads
Christos Fountzilas
Principal Investigator
Roswell Park Cancer Institute